ANXA10 suppresses papillary thyroid carcinoma apoptosis and promotes proliferation by up-regulating TSG101 thereby activating the MAPK/ERK signaling pathway (69). The gene discussed is TSG101; the disease is differentiated thyroid carcinoma.